1. 5. U.S. Food and Drug Administration. FDA action plan to enhance the collection and availability of demographic subgroup data. https://www.fda.gov/media/89307/download. Accessed February 3, 2023,
2. 1. U.S. Food and Drug Administration. Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision Making for Drug and Biological Products; Draft Guidance for Industry. https://www.fda.gov/media/152503/download. Published September 30, 2021. Accessed August 1, 2022.
3. Issues With Variability in Electronic Health Record Data About Race and Ethnicity: Descriptive Analysis of the National COVID Cohort Collaborative Data Enclave
4. Population diversity in oncology drug responses and implications to drug development
5. 3. Pharmaceutical Research and Manufacturers of America. Pharmaceutical research and manufacturers of America. https://phrma.org/resource-center/Topics/Cost-and-Value/PhRMA-Principles-on-Conduct-of-Clinical-Trials.2020. Accessed on August 22, 2022,